Checkpoint Therapeutics Inc (OQ:CKPT)

Business Focus: Biotechnology & Medical Research

INK Ultra Money Free

Latest 10 SEC filings (by transaction date) for CKPT within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET June 1st, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
May 22/20 May 21/20 Gray William Garrett Direct Ownership COMMON STOCK S - Open market or private sale -17,104 $2.00
Feb 25/20 Feb 24/20 Gray William Garrett Direct Ownership COMMON STOCK (RESTRICTED) A - Grant, award or other under Rule 16b-3(d) 157,000  
Feb 25/20 Feb 24/20 Oliviero James F III Direct Ownership COMMON STOCK (RESTRICTED) A - Grant, award or other under Rule 16b-3(d) 598,000  
Nov 22/19 Nov 20/19 Rosenwald Lindsay A Md Direct Ownership COMMON STOCK P - Open market or private purchase 100,000 $1.27
Jun 14/19 Jun 13/19 Weiss Michael S Indirect Ownership COMMON STOCK A - Grant, award or other under Rule 16b-3(d) 11,442  
Jun 14/19 Jun 13/19 Salzman Barry M Direct Ownership COMMON STOCK A - Grant, award or other under Rule 16b-3(d) 11,442  
Jun 14/19 Jun 13/19 Rosenwald Lindsay A Md Direct Ownership COMMON STOCK A - Grant, award or other under Rule 16b-3(d) 11,442  
Jun 14/19 Jun 13/19 Herskowitz Neil Direct Ownership COMMON STOCK A - Grant, award or other under Rule 16b-3(d) 11,442  
Jun 14/19 Jun 13/19 Boilen Scott Direct Ownership COMMON STOCK A - Grant, award or other under Rule 16b-3(d) 11,442  
Jun 14/19 Jun 13/19 Bechon Christian Direct Ownership COMMON STOCK A - Grant, award or other under Rule 16b-3(d) 11,442  
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for CKPT within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET June 1st, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
May 22/20 May 21/20 Gray William Garrett Direct Ownership COMMON STOCK S - Open market or private sale -17,104 $2.00
Feb 25/20 Feb 24/20 Gray William Garrett Direct Ownership COMMON STOCK (RESTRICTED) A - Grant, award or other under Rule 16b-3(d) 157,000  
Feb 25/20 Feb 24/20 Oliviero James F III Direct Ownership COMMON STOCK (RESTRICTED) A - Grant, award or other under Rule 16b-3(d) 598,000  
Nov 22/19 Nov 20/19 Rosenwald Lindsay A Md Direct Ownership COMMON STOCK P - Open market or private purchase 100,000 $1.27
Jun 14/19 Jun 13/19 Weiss Michael S Indirect Ownership COMMON STOCK A - Grant, award or other under Rule 16b-3(d) 11,442  
Jun 14/19 Jun 13/19 Salzman Barry M Direct Ownership COMMON STOCK A - Grant, award or other under Rule 16b-3(d) 11,442  
Jun 14/19 Jun 13/19 Rosenwald Lindsay A Md Direct Ownership COMMON STOCK A - Grant, award or other under Rule 16b-3(d) 11,442  
Jun 14/19 Jun 13/19 Herskowitz Neil Direct Ownership COMMON STOCK A - Grant, award or other under Rule 16b-3(d) 11,442  
Jun 14/19 Jun 13/19 Boilen Scott Direct Ownership COMMON STOCK A - Grant, award or other under Rule 16b-3(d) 11,442  
Jun 14/19 Jun 13/19 Bechon Christian Direct Ownership COMMON STOCK A - Grant, award or other under Rule 16b-3(d) 11,442  
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $CKPT

Competitors

Competitors with Recent Insider Filings
Iqvia Holdings (N:IQV)
Seattle Genetics (OQ:SGEN)
Alnylam Pharmaceuticals (OQ:ALNY)